Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults
Clinical trial NCT04417257 · TERMINATED
Trial details
- NCT number
- NCT04417257
- Sponsor
- Laurent Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2024-02-15
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.